SLC7A11 and neoplasm: Studies have found that SLC7A11 is a key target gene of BAP1, and BAP1 inhibits the expression of SLC7A11 by reducing H2Aub on the SLC7A11 promoter, promoting the occurrence of ferroptosis, and then inhibiting tumor growth.